SI21702A - Preparation of amorphous form of tamsulosin - Google Patents

Preparation of amorphous form of tamsulosin Download PDF

Info

Publication number
SI21702A
SI21702A SI200400032A SI200400032A SI21702A SI 21702 A SI21702 A SI 21702A SI 200400032 A SI200400032 A SI 200400032A SI 200400032 A SI200400032 A SI 200400032A SI 21702 A SI21702 A SI 21702A
Authority
SI
Slovenia
Prior art keywords
tamsulosin hydrochloride
tamsulosin
amorphous form
hydrochloride
preparation
Prior art date
Application number
SI200400032A
Other languages
English (en)
Slovenian (sl)
Inventor
Zoran Ham
Original Assignee
Lek Farmacevtska Druzba Dd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Lek Farmacevtska Druzba Dd filed Critical Lek Farmacevtska Druzba Dd
Priority to SI200400032A priority Critical patent/SI21702A/sl
Priority to SI200530764T priority patent/SI1713769T1/sl
Priority to DE602005015083T priority patent/DE602005015083D1/de
Priority to US10/587,376 priority patent/US20070161709A1/en
Priority to AT05715224T priority patent/ATE434604T1/de
Priority to PCT/EP2005/000875 priority patent/WO2005075416A1/en
Priority to EP05715224A priority patent/EP1713769B1/de
Publication of SI21702A publication Critical patent/SI21702A/sl

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C311/00—Amides of sulfonic acids, i.e. compounds having singly-bound oxygen atoms of sulfo groups replaced by nitrogen atoms, not being part of nitro or nitroso groups
    • C07C311/30—Sulfonamides, the carbon skeleton of the acid part being further substituted by singly-bound nitrogen atoms, not being part of nitro or nitroso groups
    • C07C311/37—Sulfonamides, the carbon skeleton of the acid part being further substituted by singly-bound nitrogen atoms, not being part of nitro or nitroso groups having the sulfur atom of at least one of the sulfonamide groups bound to a carbon atom of a six-membered aromatic ring
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/08—Drugs for disorders of the urinary system of the prostate
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Urology & Nephrology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Saccharide Compounds (AREA)
SI200400032A 2004-01-29 2004-01-29 Preparation of amorphous form of tamsulosin SI21702A (en)

Priority Applications (7)

Application Number Priority Date Filing Date Title
SI200400032A SI21702A (en) 2004-01-29 2004-01-29 Preparation of amorphous form of tamsulosin
SI200530764T SI1713769T1 (sl) 2004-01-29 2005-01-28 Priprava amorfne oblike tamsulozina
DE602005015083T DE602005015083D1 (de) 2004-01-29 2005-01-28 Amorphes tamsulosin-hydrochlorid
US10/587,376 US20070161709A1 (en) 2004-01-29 2005-01-28 Amorphous tamsulosin hydrochloride
AT05715224T ATE434604T1 (de) 2004-01-29 2005-01-28 Amorphes tamsulosin-hydrochlorid
PCT/EP2005/000875 WO2005075416A1 (en) 2004-01-29 2005-01-28 Amorphous tamsulosin hydrochloride
EP05715224A EP1713769B1 (de) 2004-01-29 2005-01-28 Amorphes tamsulosin-hydrochlorid

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
SI200400032A SI21702A (en) 2004-01-29 2004-01-29 Preparation of amorphous form of tamsulosin

Publications (1)

Publication Number Publication Date
SI21702A true SI21702A (en) 2005-08-31

Family

ID=34836935

Family Applications (2)

Application Number Title Priority Date Filing Date
SI200400032A SI21702A (en) 2004-01-29 2004-01-29 Preparation of amorphous form of tamsulosin
SI200530764T SI1713769T1 (sl) 2004-01-29 2005-01-28 Priprava amorfne oblike tamsulozina

Family Applications After (1)

Application Number Title Priority Date Filing Date
SI200530764T SI1713769T1 (sl) 2004-01-29 2005-01-28 Priprava amorfne oblike tamsulozina

Country Status (6)

Country Link
US (1) US20070161709A1 (de)
EP (1) EP1713769B1 (de)
AT (1) ATE434604T1 (de)
DE (1) DE602005015083D1 (de)
SI (2) SI21702A (de)
WO (1) WO2005075416A1 (de)

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH066565B2 (ja) * 1986-07-21 1994-01-26 山之内製薬株式会社 光学活性なベンゼンスルホンアミド誘導体の製造法
US6395300B1 (en) * 1999-05-27 2002-05-28 Acusphere, Inc. Porous drug matrices and methods of manufacture thereof
US6835853B2 (en) * 2001-10-31 2004-12-28 Synthon Bv Process for resolution of tamsulosin and compounds, compositions, and processes associated therewith
DE20220415U1 (de) * 2001-11-07 2003-10-09 Synthon Bv Tamsulosin-Tabletten

Also Published As

Publication number Publication date
ATE434604T1 (de) 2009-07-15
EP1713769A1 (de) 2006-10-25
EP1713769B1 (de) 2009-06-24
US20070161709A1 (en) 2007-07-12
SI1713769T1 (sl) 2009-10-31
WO2005075416A1 (en) 2005-08-18
DE602005015083D1 (de) 2009-08-06

Similar Documents

Publication Publication Date Title
RU2733412C2 (ru) Поликристаллическая форма свободного основания или соли присоединения кислоты ингибитора egfr, способ её получения и применение
Yan et al. Thermodynamics and preliminary pharmaceutical characterization of a melatonin–pimelic acid cocrystal prepared by a melt crystallization method
WO2017008773A1 (en) Crystalline forms of obeticholic acid
JP2017521438A (ja) ｃ−Ｍｅｔ阻害剤の結晶性フリー塩基またはそれらの結晶性酸性塩、およびそれらの製造方法および用途
EP3243824A1 (de) Feste formen von freier ibrutinib-base
EP3256474B1 (de) Ibrutinib-sulfatsalz
EP3283491A1 (de) Neue formen von ixazomibcitrat
JP2019509308A (ja) １−（５−（２，４−ジフルオロフェニル）−１−（（３−フルオロフェニル）スルホニル）−４−メトキシ−１ｈ−ピロール−３−イル）−ｎ−メチルメタンアミン塩の新規な結晶形
WO2016127963A1 (en) Solid forms of palbociclib salts
WO2014192903A1 (ja) ジベンジルアミン構造を有するピリミジン化合物の新規形態
JP7152122B2 (ja) エダラボン塩
TWI449705B (zh) １１－（２－吡咯啶－１－基－乙氧基）－１４，１９－二－５，７，２６－三氮雜－四環〔１９．３．１．１（２，６）．１（８，１２）〕二十七碳－１（２５），２（２６），３，５，８，１０，１２（２７），１６，２１，２３－十烯檸檬酸鹽
TWI457342B (zh) １１－（２－吡咯啶－１－基－乙氧基）－１４，１９－二－５，７，２６－三氮雜－四環〔１９．３．１．１（２，６）．１（８，１２）〕二十七碳－１（２５），２（２６），３，５，８，１０，１２（２７），１６，２１，２３－十烯順丁烯二酸鹽
WO2016058564A1 (en) Salts of bedaquiline
SI21702A (en) Preparation of amorphous form of tamsulosin
SK9752000A3 (en) Thermodynamically stable form of (r)-3-[ [(4-fluorophenyl) sulphonyl]amino]-1,2,3,4-tetrahydro-9h-carbazole-9-propanoic acid (ramatroban)
CN114026088A (zh) Jak2抑制剂的结晶形式
SI21616A (sl) Nove kristalne oblike karvedilola
Chen et al. Pharmaceutical cocrystals of nomegestrol acetate with superior dissolution
WO2012150183A1 (en) Crystalline sodium salt of an hiv integrase inhibitor
WO2016127962A1 (en) An amorphous solid form of suvorexant with sulphuric acid
EP3372592A1 (de) Feste formen von lesinurad aminsälze
WO2016198031A1 (en) A salt of bedaquiline with citric acid
EA043392B1 (ru) Новая соль ингибитора bcl-2, соответствующая кристаллическая форма, способ их получения и фармацевтические композиции, которые их содержат
JP2009536208A (ja) 結晶性（３−シアノ−１ｈ−インドール−７−イル）−［４−（４−フルオロフェネチル）ピペラジン−１−イル］メタノンホスフェート

Legal Events

Date Code Title Description
OO00 Grant of patent

Effective date: 20040629

KO00 Lapse of patent

Effective date: 20130903